The Claim
Exendin-4, a peptide derived from Gila monster venom, demonstrates greater metabolic stability in vivo than endogenous GLP-1 because it is resistant to degradation by the enzyme DPP-4, resulting in prolonged activation of GLP-1 receptors.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A chemical from Gila monster spit lasts longer in the body than a natural hormone because it doesn’t break down as quickly, so it keeps working longer to control blood sugar.
See the scientific wording
Exendin-4, a peptide isolated from Gila monster venom, exhibits prolonged metabolic stability in vivo compared to endogenous GLP-1 due to resistance to DPP-4 degradation, enabling sustained activation of GLP-1 receptors.
What the research says
3 studiesThe study shows that Exendin-4 lasts longer in the body than natural GLP-1 because it breaks down more slowly, which supports the idea that it works longer to control blood sugar.
Study: In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products
The study shows that Exendin-4 breaks down slowly in liver tissue and isn't broken down by the enzyme that usually destroys natural GLP-1, which helps explain why it lasts longer in the body.
Study: Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli.
The study shows that lab-made Exendin-4 lowers blood sugar in living organisms, which supports part of the claim. But it doesn’t test why it lasts longer than natural GLP-1.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.